Why EDEM?
Altair - Indian Pharmaceutical Association (IPA) Co-Hosted Symposium on
Simulation for Pharmaceutical Manufacturing
In Co-ordination with Sarojini Naidu Vanita Pharmacy Maha Vidyala
Efficient handling and processing of particulates are critical to the profitable manufacture of pharmaceutical products. Over 75% of all pharmaceutical products are in the solid dosage form and particulates are involved in almost every stage of the manufacturing process.
Particulate materials are ubiquitous in pharmaceutical manufacturing but exhibit complex mechanical behaviour and high sensitivity to ambient conditions while being subject to poorly understood stress states in processes that are largely experimentally opaque. Consequently, a diverse set of problems such as low dosing control, size and component segregation, unwanted attrition or agglomeration, non-uniform mixing, non-uniform compaction, tablet capping and chipping, and failure of process scale-up and others persist, increasing time to market and manufacturing costs. What is needed to overcome these challenges is insight beyond the one obtained through physical testing alone and this is where Altair EDEM simulation comes into play.
Speakers
Dr. V. Venkateshwarlu
Managing Director - Neuheit Pharma Technologies
Dr. B. Prabha Shankar
Chairman & Managing Director - Leads Pharma
Sridevi Challa
Group Head Formulation Division -Novartis
Dr. Ravi Pyaraka
Managing Director - PharmaDEM Solutions
Senthil Arumugam
Director of APAC Sales, DEM Technology - Altair